Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of GW406381 versus placebo and celecoxib in adults with osteoarthritis of the knee
2005-000149-12Phase 3Completed
- Sponsor
- GSK
- Start
- Mar 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of GW406381 in knee osteoarthritis (OA) (7 arms), sponsored by GSK. Primary endpoint: Change from baseline to week 12 in WOMAC pain subscale score. Started Mar 2005; status: completed.
02
Drugs
GW406381
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2005-000149-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000149-12.